Alzhheimer’s
EU nod for Lilly brain diagnostic
January 18, 2013Research and Development, Sales and Marketing Alzhheimer's, Amyvid, brain, lilly
Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …
